Zoe Tasma

Agonist bias and agonist‐dependent antagonism at corticotrophin releasing factor receptors

D. Hay, C. Walker, Zoe Tasma, 2020, Pharmacology research & perspectives.

Characterisation of agonist signalling profiles and agonist‐dependent antagonism at PACAP‐responsive receptors: Implications for drug discovery

M. Brimble, D. Hay, C. Walker, 2021, British journal of pharmacology.

Scale-Up Production Of Extracellular Vesicles From Mesenchymal Stromal Cells Isolated From Pre- Implantation Equine Embryos

Zoe Tasma, W. Hou, 2022 .

PAC1, VPAC1, and VPAC2 Receptor Expression in Rat and Human Trigeminal Ganglia: Characterization of PACAP-Responsive Receptor Antibodies

M. Brimble, D. Hay, S. O'Carroll, 2022, International journal of molecular sciences.

Characterization of Antibodies against Receptor Activity-Modifying Protein 1 (RAMP1): A Cautionary Tale

D. Hay, K. Caron, T. Lutz, 2022, International journal of molecular sciences.

Novel Fluorescently Labeled PACAP and VIP Highlight Differences between Peptide Internalization and Receptor Pharmacology.

M. Brimble, D. Hay, C. Walker, 2022, ACS pharmacology & translational science.

Calcitonin receptor antibody validation and expression in the rodent brain

D. Hay, P. Wookey, T. Lutz, 2022, Cephalalgia : an international journal of headache.

Tirzepatide, GIP(1-42) and GIP(1-30) display unique signaling profiles at two common GIP receptor variants, E354 and Q354

Zoe Tasma, Tayla A. Rees, Benjamin J. Buttle, 2024, Frontiers in pharmacology.